Impact of the ActTeens Program on physical activity and fitness in adolescents: a cluster randomized controlled trial.

BACKGROUND: The aim of our study was to evaluate the impact of the ActTeens Program on physical activity and health-related physical fitness among adolescents in Brazil. METHODS: The "ActTeens Program" was conducted using a cluster-randomized controlled trial during 24-week school term. The sample consisted of 317 adolescents (52.7% girls; 13.61 ± 0.70 years) from four secondary schools that were randomly assigned to intervention group (N = 169) or control group (N = 148). This school-based physical activity (PA) intervention involved two components: (i) structured physical activity sessions delivered within physical education (PE) and (ii) healthy lifestyle guidance (mHealth). The primary outcome was PA assessed using Physical Activity Questionnaire for Adolescents (PAQ-A); secondary outcomes included muscular (MF) and cardiorespiratory fitness (CRF) assessed using 90-push-up, handgrip dynamometer, standing long jump, and 20 m PACER shuttle run test. Assessments were conducted at baseline, 12- and 24-week. Intervention effects were assessed using linear mixed models (LMM). RESULTS: For the primary outcome (PA), no significant group-by-time effects were observed for physical education based-PA (0.3 score; 95%CI: -0.1; 0.6; and - 0.01 score; 95%CI: -0.03; 0.03, at 12-wk and 24-wk respectively) and total PA (-0.02 score; 95%CI: -0.2; 0.2; and - 0.01score; 95%CI: -0.2; 0.2, at 12 and 24 weeks respectively). After 24 weeks, we observed a significant group by time effects for lower body muscular fitness (12.9 cm; 95%CI, 3.2 to 22.2). CONCLUSION: The implementation of aerobic and muscle-strengthening exercises used in the ActTeens intervention did not lead to improvements in physical activity. The intervention resulted in improved lower body muscular fitness, however, we found no significant differences for upper body muscular and cardiorespiratory fitness.

Effects of aerobic exercise combined with resistance training on health-related physical fitness in adolescents: A randomized controlled trial.

Background: /Objective: This study aimed to compare the effects of two combined training methods on health-related physical fitness components in adolescents. Methods: Seventy-six adolescents (16.1 ± 1.1 years, n = 44 female) were randomized into groups of moderate-intensity continuous training combined with resistance training (MICT + RT), high-intensity interval training combined with resistance training (HIIT + RT), or Control. The training sessions were performed twice weekly for 12 weeks. The health-related physical fitness components evaluated were: body composition, muscular and cardiorespiratory fitness. Results: The intervention groups had a significant reduction in body fat percentage and improvement in abdominal repetitions and VO2peak after 12 weeks of combined exercise program (p < 0.001). Intervention effects were found to significantly reduce body fat percentage for the MICT + RT and HIIT + RT groups compared to the control group (mean difference: -3.8; 95% CI: -6.2; -1 0.3; mean difference: -4.7; 95%CI: -7.1; -2.3, respectively). For muscle fitness, significant effects of the intervention were found in increasing the number of abdominal repetitions favoring the MICT + RT group compared to the control group (mean difference: 9.5; 95% CI: 4.4; 14.7) and HIIT + RT compared to the control group (mean difference: 14.1; 95% CI 9; 19.3). For cardiorespiratory fitness, significant effects of the intervention on improving VO2peak were found in the experimental groups (MICT + RT vs Control group: mean difference: 4.4; 95% CI: 2.2; 6.6; and HIIT + RT vs. Control group: mean difference: 5.5, 95% CI: 3.3; 7.7). Conclusion: The results suggest that 12 weeks of training using MCIT + RT or HIIT + RT showed a similar effect for health-related physical fitness components in adolescents.

EFFECT OF EARLY TREATMENT WITH FLUVOXAMINE ON RISK OF EMERGENCY CARE AND HOSPITALIZATION AMONG PATIENTS WITH COVID-19: THE TOGETHER RANDOMIZED PLATFORM CLINICAL TRIAL

BackgroundRecent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER randomized platform clinical trial for acutely symptomatic patients with COVID-19, we assessed the efficacy of fluvoxamine vs. placebo in preventing either extended emergency room observation or hospitalization due to COVID-19. Herein, we report the preliminary findings. MethodsThis placebo-controlled, randomized, adaptive, platform trial conducted among symptomatic Brazilian adults confirmed positive for SARS-CoV-2 included eligible patients with a known risk factor for progression to severe disease. Patients were randomly assigned to either fluvoxamine (100 mg twice daily for 10 days) or placebo. The primary endpoint was a composite outcome of emergency room observation for >6 hours or hospitalization from COVID-19 up to 28 days post randomization using intention to treat. Modified intention to treat (mITT) explored patients receiving at least 24 hours of treatment before a primary outcome event. Secondary outcomes included viral clearance at day 7, time to hospitalization, mortality, and adverse drug reactions. We used a Bayesian analytic framework to determine effects along with probability of success of intervention compared to placebo. The trial is registered at clinicaltrials.gov (NCT04727424) and is ongoing. FindingsThe study team screened 9020 potential participants for this trial. The trial was initiated on June 2, 2020, with the current protocol reporting randomization from January 15, 2021 to August 6th 2021, when the trial arms were stopped for superiority. A total of 3238 patients were allocated to fluvoxamine (n=739), placebo (n=733) and other treatments (n=1766). Herein, we report the effectiveness of fluvoxamine vs. a concurrent placebo control. The average age of participants was 50 years (range 18-102 years); 57% were female. The proportion of patients observed in an emergency room for >6 hours or admitted to hospital due to COVID-19 was lower for the fluvoxamine group compared to placebo (77/739 vs 108/733; Relative Risk [RR]: 0.71; 95% Bayesian Credible Interval [95% BCI]: 0.54 - 0.93), with a probability of superiority of 99.4% surpassing the prespecified superiority threshold of 97.6% (risk difference 4.3%). Of the composite primary outcome events, 88% were hospitalizations. Findings were similar for the mITT analysis (RR0.68, 95% BCI : 0.50- 0.91). We found no significant relative effects between the fluvoxamine and placebo groups on viral clearance at day 7 (Odds ratio [OR]: 0.75; 95% Confidence Intervals [95% CI]: 0.53 - 1.07), mortality (OR: 0.70; 95% CI: 0.36 - 1.30), time to death (Hazard ratio [HR]: 0.79; 95% CI: 0.58 - 1.08), days hospitalized (Mean Difference (MD) 1.22 days; 95% CI: 0.98 - 1.53), number of days ventilated (MD 1.10; 95% CI: 0.70 - 1.73) or other secondary outcomes. Data capturing all 28 days of follow-up will be reported after August 26th, 2021. InterpretationTreatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19, reduced the need for extended emergency room observation or hospitalization. FundingThe trial was supported by FastGrants and The Rainwater Foundation.

Health-related physical fitness indicators and clustered cardiometabolic risk factors in adolescents: A longitudinal study.

BACKGROUND/OBJECTIVE: This study examined relationships between health-related physical fitness indicators and clustered cardiometabolic risk factors in adolescents between 2014 and 2017. METHODS: The sample consisted of 93 students (60% girls), with complete data sets in both 2014 and 2017. The physical fitness components evaluated were: flexibility (sit and reach), muscular fitness (curl-up and push-up), cardiorespiratory fitness (progressive aerobic cardiovascular endurance run), and body fat (BMI). The cardiometabolic risk factors were: waist circumference, blood pressure, high-density lipoprotein cholesterol (HDL-C), triglycerides and fasting blood glucose. Z-scores were calculated for each risk factor, with the sum of risk factor z-scores values used to represent clustered cardiometabolic risk. RESULTS: The results of cross-sectional analysis indicated that muscle fitness (curl-up: ß = -0.37, p < 0.001; push-up: ß = -0.38, p < 0.005) and cardiorespiratory fitness (ß = -0.56, p < 0.001) were inversely associated with clustered cardiometabolic risk, with BMI positively associated (ß = 0.58, p < 0.001). In the longitudinal analysis, cardiorespiratory fitness (ß = -0.33; p < 0.005) and body fat (ß = 0.46, p < 0.001) demonstrated a significant association with clustered cardiometabolic risk. However, no significant associations between the health-related physical fitness and clustered cardiometabolic risk were observed after adjustment for baseline values. CONCLUSION: Our cross-sectional findings highlight the importance of health-related physical fitness indicators to adolescents. In regarding the longitudinal analysis, further studies are needed in order to clarify the influence of physical fitness in the adolescence and cardiometabolic risk later in life.